Comment on Inovio Pharmaceuticals Stock Soars on Encouraging HIV Vaccine Readout

Inovio Pharmaceuticals Stock Soars on Encouraging HIV Vaccine Readout

Shares of the clinical-stage biotech Inovio Pharmaceuticals (NASDAQ: INO) gained as much as 38% today due to a positive early-stage readout for its experimental HIV vaccine called Pennvax-GP.Digging into the details, the company reported that 71 out of 76 (93%) evaluable participants exhibited either a CD4+ or CD8+ cellular immune response to at least one of the vaccine's four antigens.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News